Investor Centre

Stay informed with the latest updates on our performance, announcements, and shareholder information.

Contact investor relations

-

Current Stockprice (AUD)

-

Market Cap (AUD)

-

Volume

Select date range:

Date text...

Loading...

- of

Analyst Coverage

Read independent insights and analysis on our company’s performance, provided by analysts tracking our progress.

January 2025

East Coach Research: Revolutionising Autism and ADHD Diagnosis with AI-Powered Smartphone Technology

October 2024

Lodge Partners Initiation Research Report BlinkLab Ltd (ASX:BB1) ASD & ADHD

March 2024

Bioshares, Australia’s Independent Biotech Investment Resource, est.1999 – 11

The BlinkLab Pipeline

Below you find the latest version of our product pipeline. Any updates on our progress you will read in the news & announcement section.

Product
Name

Product
Description

Clinical Feasibility
Studies

Pivotal Clinical
Studies

Regulatory
Approval

Post
Authorization

BlinkLab Dx 1

Autism diagnostic adjunct

BlinkLab Dx N

ADHD diagnostic adjunct

Scroll to see more

Reach out to our investor relations team.

Are you an active shareholder, or looking to become one? We are here for all your inquiries. Using the form your inquiry will be redirected to the investor relations team, getting back to you within a few days. Or, reach out to one of the team members personally.